• COVID-19 and FA

  FA MOXIe Extension Study Starts At-home Visits Due to COVID-19 Risk

  Posted by FA Forums Moderator on April 14, 2020 at 11:29 am

  

  Due to the COVID-19 crisis, Reata is implementing at-home delivery of omaveloxolone to Friedreich’s ataxia patients in the MOXIe extension study. Click to learn more.

  What do you think of this news?

  FA Forums Moderator replied 4 years ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply